This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Volastra Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Prashanna Vijayachandran: Innovator in ENPP1 Inhibition
Introduction
Prashanna Vijayachandran is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). His work is crucial for advancing therapeutic options for diseases mediated by this enzyme.
Latest Patents
Prashanna holds 1 patent for his invention titled "Heterocyclic inhibitors of ENPP1." This patent focuses on the development of triazolopyrimidine and imidazolopyrimidine inhibitors of ENPP1. The disclosure outlines the compositions and methods for using these compounds to treat diseases associated with ENPP1.
Career Highlights
Prashanna is currently associated with Volastra Therapeutics, Inc., where he continues to innovate in the field of drug development. His expertise in creating effective inhibitors has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Prashanna collaborates with talented individuals such as Piotr Nieczypor and Gydo Van Der Heijden. These partnerships enhance the research and development efforts at Volastra Therapeutics, Inc.
Conclusion
Prashanna Vijayachandran's work in developing ENPP1 inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new treatments that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile